A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
In: Bone Marrow Transplantation, Jg. 27 (2001-02-01), Heft 3, S. 269-278
Online
academicJournal
Zugriff:
A single cycle of high-dose chemotherapy with stem cell support (HDC) in women with responsive metastatic breast cancer (BC) consistently achieves over 50% complete and near complete response (CR/nCR). This significant cytoreduction results in a median event-free survival (EFS) of 8 months, and approximately 20% 3-year and 16% 5-year EFS in selected patients. To improve long-term outcomes, new strategies to treat minimal residual tumor burden are needed. Increased total dose delivered can be achieved with two cycles of HDC. Critical design issues include shortening induction chemotherapy to avoid development of drug resistance and the use of different agents for each HDC cycle. We have determined the maximum tolerated dose (MTD) for paclitaxel combined with high-dose melphalan in the context of a double transplant and explored the impact of a short induction phase. Between June 1994 and August 1996, we enrolled 32 women with metastatic BC on to this phase I double transplant trial. Induction consisted of doxorubicin 30 mg/m2/day days 1–3 given for 2 cycles every 14 days with G-CSF 5 μg/kg s.c. days 4–12. Stem cell collection was performed by leukapheresis in each cycle when the WBC recovered to above 1000/μl. Patients with stable disease or better response to induction were eligible to proceed with HDC. HDC regimen I (TxM) included paclitaxel with dose escalation from 0 to 300 mg/m2 given on day 1 and melphalan 180 mg/m2 in two divided doses given on day 3. HDC regimen II was CTCb (cyclophosphamide 6 g/m2, thiotepa 500 mg/m2, and carboplatin 800 mg/m2 total doses) delivered by 96-h continuous infusion. At the first dose level of 150 mg/m2 paclitaxel by 3 h infusion, four of five patients developed dose-limiting toxicity consisting of diffuse skin erythema and capillary leak syndrome. Only two of these five completed the second transplant. Subsequently,... [ABSTRACT FROM AUTHOR]
Titel: |
A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
|
---|---|
Autor/in / Beteiligte Person: | Elias, A D ; Richardson, P ; Avigan, D ; Ibrahim, J ; Joyce, R ; Demetri, G ; Levine, J ; Warren, D ; Arthur, T ; Reich, E ; Wheeler, C ; Frei III, E ; Ayash, L |
Link: | |
Zeitschrift: | Bone Marrow Transplantation, Jg. 27 (2001-02-01), Heft 3, S. 269-278 |
Veröffentlichung: | 2001 |
Medientyp: | academicJournal |
ISSN: | 0268-3369 (print) |
DOI: | 10.1038/sj.bmt.1702780 |
Schlagwort: |
|
Sonstiges: |
|